Last reviewed · How we verify
NCT05825651
Long COVID and Its Associations With Health Outcomes in Older Adults
trial testing no interventions in Long COVID in 11,527 participants. Participants enrolled and being followed up; not accepting new ones.
1 August 2026
Quick facts
| Lead sponsor | Peking University |
|---|---|
| Status | Active, enrolled |
| Study type | OBSERVATIONAL |
| Enrollment | 11,527 |
| Start date | 24 April 2023 |
| Primary completion | 1 August 2026 |
| Estimated completion | 31 August 2026 |
| Sites | 1 location across China |
Drugs / interventions tested
- no interventions — full drug profile →
Conditions studied
- Long COVID — all drugs for Long COVID →
- COVID-19 Pandemic — all drugs for COVID-19 Pandemic →
- Elderly Infection — all drugs for Elderly Infection →
- Vaccine Reaction — all drugs for Vaccine Reaction →
Sponsor
Peking University
Who can join
60 and older, any sex, with Long COVID or COVID-19 Pandemic. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The Peking University Health Cohort in Anning, Yunnan (PKUHC-AN) is a prospective cohort study carried out in Anning, Yunnan. The primary aim of this study is to investigate the impact of COVID-19 on older adults' health, and to provide high-quality evidence of real world research for the optimization of prevention and control strategies of COVID-19 and other emerging infectious diseases. Data will be collected regarding health status, history of COVID-19 infections and vaccines, lifestyle and socioeconomic characteristics, as well as the short- and long-term health outcomes.
Publications & conference data
3 peer-reviewed publications reference this trial (live from Europe PMC):
-
Development and validation of prediction models for poor sleep quality among older adults in the post-COVID-19 pandemic era.
Du M, Li M, Yu X, Wang S, et al · · 2023 · cited 4× · PMID 38010392 · DOI 10.1080/07853890.2023.2285910 -
Interaction between economic status and healthy lifestyle in long COVID among Chinese older population: a cross-sectional study.
Wang Y, Li M, Zhang B, Feng Y, et al · · 2024 · cited 3× · PMID 39327050 · DOI 10.1136/bmjopen-2023-082314 -
Effects of sleep quality on the risk of various long COVID symptoms among older adults following infection: an observational study.
Du M, Yang P, Li M, Yu X, et al · · 2025 · PMID 39789478 · DOI 10.1186/s12877-025-05675-5
Verify or expand the search:
- PubMed search for NCT05825651
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of no interventions
Trials testing the same drug.
- NCT06824493 — Orthodontic Treatment on Oral Microbiota and Salivary Proteins · not yet recruiting
- NCT04529967 — Child-Parent Familial Hypercholesterolemia Screening · recruiting
- NCT06778746 — Use of Biologics for Severe Asthma in Hong Kong · recruiting
- NCT06276153 — Construction of Multicenter Retrospective Registry Cohort Database for Gallbladder Cancer · not yet recruiting
- NCT05896956 — The Construction of Clinical Database and Multiomics Biobank Based on a Multicentral Prospective Cohort of Benign and Ma · not yet recruiting
Other recruiting trials for Long COVID
Currently open trials in the same condition.
- NCT05931497 — Sauna for Long Covid · NA · recruiting
- NCT06452095 — Recovering From COVID-19 Lingering Symptoms Adaptive Integrative Medicine Trial - Effect of Hyperbaric Oxygen Therapy fo · NA · recruiting
- NCT07316127 — Immunoadsorption in Autoimmune Long COVID · Phase 2 · recruiting
- NCT07435805 — Long-Term Health Effects of Previous COVID-19 in Patients Undergoing Preoperative Anesthesia Evaluation · recruiting
- NCT07278206 — Brain Stimulation in Long COVID · NA · recruiting
Other Peking University trials
Trials by the same sponsor.
- NCT07519122 — Fangshan Active Nutrition Initiative · NA · not yet recruiting
- NCT07466238 — HAIC Plus Systemic Therapy as De-escalation Therapy Strategy for Biliary Tract Cancer · NA · recruiting
- NCT07480525 — Efficacy and Mechanisms of Escitalopram in Drug-Naïve First-Episode Major Depressive Disorder · NA · not yet recruiting
- NCT07454031 — Intraperitoneal PX in Combination With Nab-Paclitaxel in Patients With Peritoneal Metastatic Mucinous Adenocarcinoma · Phase 1 · not yet recruiting
- NCT07466225 — HAIC Plus Lenva and PD-1 for Advanced HCC With Macrovascular or Biliary Invasion · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05825651 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Peking University
- Last refreshed: 12 December 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05825651.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing